Project Hypnos: The Impact of a Brief Hypnosis Intervention on Single-limb Dynamic Balance in People With Chronic Ankle Instability

April 26, 2024 updated by: Ohio University

The Impact of a Brief Hypnosis Intervention on Single-limb Dynamic Balance in People With Chronic Ankle Instability: Enhancing and Limiting Psychological Factors, Perceived and Performance-based Ankle Stability, and Heart-rate Variability

This study will determine the relationship of one's self-reported awareness of their body and their ankle motor control for people with chronic ankle instability. This study will further identify the correlates between certain psychological characteristics (i.e., fear and anxiety) and autonomic nervous system arousal (i.e., heart rate variability). Furthermore, this study will elucidate the potential impact of a brief hypnosis practice on balance performance.

Study Overview

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Athens, Ohio, United States, 45701
        • Ohio University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • History of one significant ankle sprain
  • Experiences of instability in the ankle, determined by a score of > 11 on the Identification of Functional Ankle Instability (IdFAI) questionnaire
  • An overall sensation of disability, determined by a score of < 90% on the Functional Ankle Ability Measure (FAAM) questionnaire

Exclusion Criteria:

  • If the participant's initial ankle sprain was within the past twelve months or the most recent ankle sprain was within the past three months, the participant was excluded from eligibility
  • A history of lower extremity surgery
  • A fracture to the lower extremity
  • Any acute musculoskeletal injuries to lower extremities in the past three months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Self-hypnosis
The audio-guided self-hypnosis practice was sourced from the Reveri App (reveri.com), developed by Dr. David Spiegel, and entitled "Hypnosis Prep for Workout"
Participants listened to an 8-minute audio-guided self-hypnosis related to improving their physical performance
Participants listened to an 8-minute video on ankle sprain diagnosis, prognosis, and treatment
Active Comparator: Ankle Education
The ankle education video, entitled "Ankle Sprain Rehab Exercises" was sourced from the Physio Tutors YouTube channel
Participants listened to an 8-minute audio-guided self-hypnosis related to improving their physical performance
Participants listened to an 8-minute video on ankle sprain diagnosis, prognosis, and treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance test 1
Time Frame: Through the study completion, up to 8 days from baseline assessment. Assessed at pre-intervention and post-intervention for sessions 1 and 2
Biodex Stability System
Through the study completion, up to 8 days from baseline assessment. Assessed at pre-intervention and post-intervention for sessions 1 and 2
Balance test 2
Time Frame: Through the study completion, up to 8 days from baseline assessment. Assessed at pre-intervention and post-intervention for sessions 1 and 2
Y-Balance test
Through the study completion, up to 8 days from baseline assessment. Assessed at pre-intervention and post-intervention for sessions 1 and 2
Heart rate variability
Time Frame: Through the study completion, up to 8 days from baseline assessment. Assessed at pre-intervention and post-intervention for sessions 1 and 2
HRV was captured for 5 minutes using a three-lead electrocardiogram at the beginning of each of the two lab sessions
Through the study completion, up to 8 days from baseline assessment. Assessed at pre-intervention and post-intervention for sessions 1 and 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ankle disability measure 1
Time Frame: T0, Baseline/Enrollment
Identification of Functional Ankle Instability, used for eligibility screening
T0, Baseline/Enrollment
Ankle disability measure 2
Time Frame: T0, Baseline/Enrollment
Functional Ankle Ability Measure
T0, Baseline/Enrollment
Interoceptive awareness measure 1
Time Frame: T0, Baseline/Enrollment
Mindful Presence - Bodily Awareness
T0, Baseline/Enrollment
Interoceptive awareness measure 2
Time Frame: T0, Baseline/Enrollment
Multidimensional Assessment of Interoceptive Awareness (MAIA-2)
T0, Baseline/Enrollment
Emotional Distress-Anxiety
Time Frame: T0, Baseline/Enrollment
PROMIS Emotional Distress-Anxiety item bank
T0, Baseline/Enrollment
Kinesiophobia
Time Frame: T0, Baseline/Enrollment
Tampa Scale of Kinesiophobia (TSK-11)
T0, Baseline/Enrollment
Pain self-efficacy
Time Frame: T0, Baseline/Enrollment
Pain Self-Efficacy Questionnaire (PSEQ-10)
T0, Baseline/Enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Nicholas Karayannis, MPT, PhD, Ohio University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2023

Primary Completion (Actual)

November 27, 2023

Study Completion (Actual)

November 27, 2023

Study Registration Dates

First Submitted

April 2, 2024

First Submitted That Met QC Criteria

April 26, 2024

First Posted (Actual)

April 29, 2024

Study Record Updates

Last Update Posted (Actual)

April 29, 2024

Last Update Submitted That Met QC Criteria

April 26, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Sprains

Clinical Trials on Self-Hypnosis

3
Subscribe